Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2023-04-06 00:00:00 ET · period of report 2023-04-04 · accession 0001162194-23-000021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-06 | 2023-04-04 | LAB | Kim Hanjoon Alex | COO | M - OptEx | $0.00 | +70.2K | 70.2K | New | $0 |
| D | 2023-04-06 | 2023-04-04 | LAB | Kim Hanjoon Alex | COO | M - OptEx | $0.00 | -70.2K | 210.5K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-04 | M | A | 70,183 | $0.00 | 70,183 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2023-04-04 | M | D | 70,183 | $0.00 | 210,549 | D | — · — to — | 70,183 Common Stock | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. (F2) Restricted Stock Units vest in four equal annual installments beginning April 4, 2023. |